Post-emergency Management of Patients With Transient Ischemic Attack

December 6, 2023 updated by: Centre Hospitalier Henri Duffaut - Avignon

A transient ischemic attack (TIA) is a momentary neurological dysfunction due to a brief cessation of blood flow to a region of the brain, resulting in typical signs of stroke (hemiplegia, aphasia, dysarthria), but whose clinical symptoms typically last less than an hour, with no visible lesion on imaging. This diagnosis remains difficult and is essentially based on the clinical judgment of the physician.

Because a TIA can be a "pre-alarm" for stroke in 20-30% of cases, it needs to be treated appropriately and as early as possible in the emergency department. Stroke rates after untreated TIA are 5% within 48 hours, 10% within one month and 20% within one year. This risk is calculated using the ABCD² score which is based on the patient's risk factors and the clinical manifestations of TIA. Patients with a score ≥ 3 should be hospitalized as soon as possible for a complete medical evaluation. However, this score has not been scientifically validated, and several specialists agree that all TIAs should be evaluated immediately. Preventing stroke is a major public health issue because it is a serious, disabling and sometimes fatal disease. Given the seriousness of the progression from TIA to stroke, the French National Authority for Health has issued a series of management recommendations. However, in practice, these guidelines remain complicated to follow and patients management may vary and be more or less effective.

Therefore, the aim of this study is to highlight the differences in how inpatients and outpatients are managed. Following these observations, solutions will be sought to make the care and management of these patients more efficient and more in line with recommendations.

Study Overview

Study Type

Observational

Enrollment (Estimated)

140

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Provence-Alpes-Côte d'Azur
      • Avignon, Provence-Alpes-Côte d'Azur, France
        • Recruiting
        • Centre Hospitalier d'Avignon
        • Contact:
        • Contact:
        • Principal Investigator:
          • Yohan Fouilhe, Medical Intern
        • Sub-Investigator:
          • Ludovic Sauvage, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients with a diagnosis of TIA in the emergency department

Description

Inclusion Criteria:

  • Patient over 18 years old.
  • Consultation in the emergency department.
  • Suspected TIA diagnosed by emergency physician.
  • Duration of TIA symptoms <1 hour.

Exclusion Criteria:

  • Validation MRI performed prior to suspected TIA.
  • Patient hospitalized for a condition other than TIA, including stroke.
  • Patient referred to another hospital for further examination.
  • Pregnant women.
  • Patient unable to understand and answer a questionnaire.
  • Patient under legal protection.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
TIA patients
Satisfaction questionnaire to assess how TIA patients feels about their medical care.
Recording appointments and results of examinations and consultations in TIA management

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Assess time between arrival in the emergency department for suspected TIA patients and MRI.
Time Frame: Baseline
Baseline

Secondary Outcome Measures

Outcome Measure
Time Frame
Time between arrival in the emergency department and MRI by departments.
Time Frame: Baseline
Baseline
Time between arrival in the emergency department and MRI by ABCD² score.
Time Frame: Baseline
Baseline
Percentage of patients with complete TIA management by departments.
Time Frame: Baseline
Baseline
Hospitalization times according to care units
Time Frame: Baseline
Baseline
Hospitalization times according to complete TIA management
Time Frame: Baseline
Baseline
Percentage of patients with secondary event, according to complete TIA management
Time Frame: Baseline
Baseline
Number of outpatients without complete TIA management one month after TIA.
Time Frame: At 1 month follow-up
At 1 month follow-up
Patient satisfaction with a short questionnaire
Time Frame: At 1 month follow-up
At 1 month follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Yohan Fouilhe, Medical Intern, Centre Hospitalier d'Avignon, Service des urgences

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 16, 2023

Primary Completion (Estimated)

May 16, 2024

Study Completion (Estimated)

June 16, 2024

Study Registration Dates

First Submitted

November 17, 2023

First Submitted That Met QC Criteria

December 6, 2023

First Posted (Estimated)

December 14, 2023

Study Record Updates

Last Update Posted (Estimated)

December 14, 2023

Last Update Submitted That Met QC Criteria

December 6, 2023

Last Verified

December 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Transient Ischemic Attack

Clinical Trials on Satisfaction questionnaire

3
Subscribe